Kezar Life Sciences, Inc. — Director's Dealing 2021

Mar 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2019-05-30

Reporting Person: Economides Vassiliki (SVP, Strategy & External Aff.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-30	Common Stock	P	750	$10.19	Acquired	11320	Direct

Footnotes

F1: Total reflects 3,000 shares of common stock acquired on November 15, 2020 through the Company's 2018 Employee Stock Purchase Plan.